Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Kent

Showing results (391-400 of 394) with videos related to

Pageof 40
Sort By:
You have reached the last page of results.This site can display upto 394 results.
BMJ Open|November 5, 2017
Protocol for the HAPPY Hearts study: cardiovascular screening for the early detection of future adverse cardiovascular outcomes in middle-aged and older women: a prospective, observational cohort studyKevin F Boreskie, D Scott Kehler, Eduardo C Costa, et al.
Nature Communications|February 20, 2021
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19Adam K Wheatley, Jennifer A Juno, Jing J Wang, et al.
Frontiers in Global Women'S Health|March 7, 2024
A consensus statement on perinatal mental health during the COVID-19 pandemic and recommendations for post-pandemic recovery and re-buildLeanne Jackson, Mari Greenfield, Elana Payne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 11, 2025
Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancerP Harter, F Trillsch, A Okamoto, et al.
Pageof 40

Showing results (391-400 of 394) with videos related to

Sort By:
Pageof 40
You have reached the last page of results.This site can display upto 394 results.
BMJ Open|November 5, 2017
Protocol for the HAPPY Hearts study: cardiovascular screening for the early detection of future adverse cardiovascular outcomes in middle-aged and older women: a prospective, observational cohort studyKevin F Boreskie, D Scott Kehler, Eduardo C Costa, et al.
Nature Communications|February 20, 2021
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19Adam K Wheatley, Jennifer A Juno, Jing J Wang, et al.
Frontiers in Global Women'S Health|March 7, 2024
A consensus statement on perinatal mental health during the COVID-19 pandemic and recommendations for post-pandemic recovery and re-buildLeanne Jackson, Mari Greenfield, Elana Payne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 11, 2025
Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancerP Harter, F Trillsch, A Okamoto, et al.
Pageof 40